ERYVAC VACCINE

Šalis: Australija

kalba: anglų

Šaltinis: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Veiklioji medžiaga:

ERYSIPELOTHRIX RHUSIOPATHIAE; THIOMERSAL

Prieinama:

ZOETIS AUSTRALIA PTY LTD

INN (Tarptautinis Pavadinimas):

E.rhusiopathiae

Vaisto forma:

PARENTERAL LIQUID/SOLUTION/SUSPENSION

Sudėtis:

ERYSIPELOTHRIX RHUSIOPATHIAE VACCINE-GENERAL Active 0.0 P; THIOMERSAL MERCURY Other 0.1 mg/ml

Vienetai pakuotėje:

250mL; 500mL; 50mL

Klasė:

VM - Veterinary Medicine

Pagaminta:

ZOETIS AUSTRALIA

Farmakoterapinė grupė:

LAMB | PIGS | SHEEP | BOAR | EWE | GILT | HOGGET | LAMB | OVINE | PIGLET | RAM | SOW | SWINE | WEANER | WETHER

Gydymo sritis:

IMMUNOTHERAPY

Terapinės indikacijos:

ERYSIPELAS - SWINE | ERYSIPELOTHRIX ARTHRITIS | VACCINE | EQUINE ROTAVIRUS | SWINE ERYSIPELAS

Produkto santrauka:

Poison schedule: 0; Withholding period: WHP:NIL ESI: ESI NOT APPLICABLE; Host/pest details: LAMB: [ERYSIPELOTHRIX ARTHRITIS, VACCINE]; PIGS: [ERYSIPELAS - SWINE, VACCINE]; SHEEP: [ERYSIPELOTHRIX ARTHRITIS, VACCINE]; Poison schedule: 0; Withholding period: ; Host/pest details: LAMB: [ERYSIPELOTHRIX ARTHRITIS, VACCINE]; PIGS: [ERYSIPELAS - SWINE, VACCINE]; SHEEP: [ERYSIPELOTHRIX ARTHRITIS, VACCINE]; For the control of erysipelas of swine and arthritis of lambs caused by Erysipelothrix rhusiopathiae (insidiosa) infection.

Autorizacija statusas:

Registered

Leidimo data:

2023-07-01

Pakuotės lapelis

----------------------------------------------
•
•
APPENDIX 2
Australian Government
Australian Pesticides
and
Veterinary Medicines Authority
RLP
Approved
TEMPLATE
FOR
RELEVANT
LABEL
PARTICULARS
(RLPs)
(Veterinary
Products)
Select appropriate:
[J
New
Product
(include
all
applicable
RLPs)
OR
It
Variation
(highlight
instructions
that
are
being
varied).
Approval
no.
of
label
being
varied:
53385/60234
Signal
heading:
Product
name:
Active
constituent/s:
Statement
of
claims:
Net
contents:
Directions
for
Use
Heading:
Restraints:
Contraindications:
Precautions:
FOR
ANIMAL
TREATMENT
ONLY
Eryvac® Vaccine
Erysipelothrix rhusiopathiae:::
40
IU/dose (formol culture)
Eryvac
is
an
adjuvanted vaccine prepared from a formalin killed culture of a
highly antigenic strain of
Erysipelothrix rhusiopathiae (insidiosa)
_:::
40 IU/dose.
The adjuvant, which
is
an
aluminium salt, increases the level and duration of
the immunity conferred
by
the vaccine.
The type of adjuvant used ensures
maximum protection of stock with minimum risk of local reactions at
the site of
injection. Thiomersal
0.1
mg/ml
is
added
as
a preservative. The vaccine has
been fully
tested
and found to conform to accepted standards of potency, safety
and sterility.
For
the
control
of
erysipelas
of
swine
and
arthritis
of
lambs
caused
by
Erysipelothrix
rhusiopathiae (insidiosa)
infection.
50
[250,
500]
Doses;
50
[250,
500]
ml
MODE
OF
ISSUE
Eryvac
is
available
in
50
ml,
250
ml
and
500
ml
packs.
DIRECTIONS FOR USE
Read
the
enclosed leaflet
for
full
instructions
Contents
must
be
left
in outer package until immediately before
use
Shake well before use and keep
thoroughly
mixed
during
use
This
product
can be
stored
and
used
for
up
to
30
days
after
first
opening
Handle aseptically and
store
refrigerated and protected
from
light
Please refer
to
the resealing
section
and
the
product
insert
for
further
information
on storage and handling
after
opening.
N/A
N/A
N/A
18 Wormald Street, Symonston
ACT
2609
PO Box 6182, Kingston ACT 2604 Australia
Tel:
+61
2 6210 4700 Fax:
+61
2 6210

Prekės savybės

PRODUCT NAME: ERYVAC® VACCINE
PAGE: 1 OF 5
THIS REVISION ISSUED: JUNE, 2010
MATERIAL SAFETY DATA SHEET
Issued by: Pfizer Australia Pty Ltd
Phone: [phone]
SECTION 1 - IDENTIFICATION OF THE MATERIAL AND SUPPLIER
Pfizer Australia Pty Ltd
38-42 Wharf Road
West Ryde NSW 2114
Tel: [phone]
Fax: [phone]
____________________________________
PFIZER AUSTRALIA PTY LTD
A.B.N. 50 008 422 348
CHEMICAL NATURE:
Erysipelas Vaccine for Pigs, Inactivated.
TRADE NAME:
ERYVAC
® VACCINE
PFIZER MSDS CODE:
0822
PRODUCT USE:
Animal vaccine for the control of erysipelas in pigs.
CREATION DATE:
AUGUST, 2004
THIS VERSION ISSUED:
JUNE, 2010
and is valid for 5 years from this date.
SECTION 2 - HAZARDS IDENTIFICATION
STATEMENT OF HAZARDOUS NATURE
This product is classified as:
Not classified as hazardous according to the criteria of SWA
Australia.
Not a Dangerous Good according to the Australian Dangerous Goods (ADG)
Code.
RISK PHRASES:
Not Hazardous - No criteria found.
SAFETY PHRASES:
Not Hazardous - No criteria found.
SUSDP CLASSIFICATION:
None allocated (S2 NZ)
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good.
UN NUMBER:
None allocated
E
E
E
M
M
M
E
E
E
R
R
R
G
G
G
E
E
E
N
N
N
C
C
C
Y
Y
Y
O
O
O
V
V
V
E
E
E
R
R
R
V
V
V
I
I
I
E
E
E
W
W
W
PHYSICAL DESCRIPTION & COLOUR
: Aqueous suspension.
ODOUR:
No data.
MAJOR HEALTH HAZARDS:
No significant risk factors have been found for this product.
P
P
P
O
O
O
T
T
T
E
E
E
N
N
N
T
T
T
I
I
I
A
A
A
L
L
L
H
H
H
E
E
E
A
A
A
L
L
L
T
T
T
H
H
H
E
E
E
F
F
F
F
F
F
E
E
E
C
C
C
T
T
T
S
S
S
INHALATION
SHORT TERM EXPOSURE:
Significant inhalation exposure is considered to be unlikely.
Available data indicates that this
product is not harmful. In addition product is unlikely to cause any
discomfort or irritation.
LONG TERM EXPOSURE:
No data for health effects associated with long term inhalation.
SKIN CONTACT:
SHORT TERM EXPOSURE:
Available data indicates that this product is not harmful. It should
present no hazards in
normal use. However product may be mildly irritating, but is unlikely
t